Tuberculosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Tuberculosis is caused by Mycobacterium tuberculosis, a bacterium that primarily infects the lungs. Upon inhalation, the bacteria are engulfed by alveolar macrophages but can evade destruction, leading to the formation of granulomas, which are clusters of immune cells attempting to contain the infection.

• Secondary mechanism: The bacteria can remain dormant within these granulomas for years, causing latent tuberculosis. Reactivation occurs when the immune system is compromised, leading to active disease characterized by tissue necrosis and cavitation in the lungs.

• Key complication: If untreated or in cases of immunosuppression, the infection can disseminate beyond the lungs to other organs, leading to miliary tuberculosis, which is a severe and often life-threatening form of the disease.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: History of smoking, previously treated for latent TB infection

• Current medications: Isoniazid, Vitamin B6 supplement

• Allergies: Allergic to penicillin

Current Presentation:

• Chief complaint: Persistent cough and shortness of breath

• Key symptoms: Night sweats, weight loss, fatigue, hemoptysis, chest pain

• Vital signs: Temperature 38.5°C (101.3°F), Heart rate 110 bpm, Respiratory rate 24 breaths per minute, Blood pressure 130/85 mmHg

Section 1

New Complications:

Following the initial diagnosis of active pulmonary tuberculosis, the patient was started on a standard four-drug antitubercular regimen, which included rifampin, isoniazid, pyrazinamide, and ethambutol, alongside continued use of a Vitamin B6 supplement to prevent isoniazid-induced neuropathy. Within a week of treatment initiation, the patient began experiencing worsening respiratory symptoms, including increased cough frequency, more pronounced hemoptysis, and significant respiratory distress. On examination, his oxygen saturation dropped to 88%, and auscultation revealed diminished breath sounds and coarse crackles over the right upper lobe. A new chest X-ray showed increased cavitation and a right-sided pleural effusion, suggesting the development of a secondary bacterial infection or possible drug-resistant TB strain.

Laboratory investigations were expanded to include sputum cultures, which demonstrated a mixed bacterial flora with the presence of Pseudomonas aeruginosa, indicating a superimposed bacterial pneumonia. Further, sputum smear microscopy revealed persisting acid-fast bacilli despite ongoing treatment, raising concerns about potential multidrug-resistant tuberculosis (MDR-TB). In light of these findings, the treatment plan was adjusted to include intravenous antibiotics targeting Pseudomonas, and the antitubercular regimen was modified pending further drug susceptibility testing. The patient's case was escalated to a multidisciplinary team for comprehensive management, including infectious disease specialists to address the complexities of MDR-TB and the ongoing risk of dissemination.

Section 2

New Complications:

Despite the adjusted treatment plan, the patient's condition continued to deteriorate over the subsequent days, signaling the emergence of new complications. Clinically, he began to exhibit signs of systemic involvement, with persistent fever spikes reaching 39.5°C (103.1°F), tachycardia with a heart rate of 115 beats per minute, and a blood pressure reading of 100/60 mmHg, suggesting potential sepsis. His respiratory distress worsened, necessitating supplemental oxygen via a high-flow nasal cannula to maintain oxygen saturation levels above 92%. Laboratory results revealed a worsening leukocytosis of 15,000/mm³ with a left shift, indicating an inflammatory response, and a C-reactive protein level that had tripled since admission, further pointing to a significant ongoing infectious process.

In addition to these systemic signs, the patient's renal function began to decline, with serum creatinine levels rising from 1.0 to 2.3 mg/dL over a few days, raising concerns for acute kidney injury potentially linked to the nephrotoxic effects of the revised antibiotic regimen. The patient's urine output decreased to less than 0.5 mL/kg/h, necessitating a reevaluation of fluid management and possible nephrology consultation. Furthermore, the patient complained of new onset right flank pain and exhibited bilateral lower extremity edema, prompting a bedside ultrasound that showed mild hydronephrosis on the right side. This constellation of findings suggested the possibility of acute pyelonephritis or obstructive uropathy as a complicating factor.

Given these developments, the healthcare team prioritized a reassessment of the patient's antibiotic regimen to balance efficacy against the risk of further renal compromise. The multidisciplinary team, including infectious disease, nephrology, and pulmonary specialists, convened to formulate an optimized treatment approach, emphasizing the need for continuous monitoring of renal function and hemodynamic status. This complicated clinical picture necessitated a detailed review of the patient's evolving condition to prevent further deterioration, address potential sepsis, and ensure appropriate management of the suspected MDR-TB and secondary infections.

Section 3

New Diagnostic Results:

In light of the patient's deteriorating condition, the healthcare team expedited additional diagnostic tests to elucidate the underlying causes of the new complications. A repeat chest X-ray showed progression of the pulmonary infiltrates with new cavitary lesions, raising concerns for possible superimposed bacterial pneumonia or worsening of the tuberculosis infection. A sputum culture was obtained, and preliminary results indicated a growth of a resistant strain of Pseudomonas aeruginosa, requiring further sensitivity testing to tailor antibiotic therapy effectively.

Concurrently, a comprehensive metabolic panel revealed worsening renal function with a serum creatinine of 2.8 mg/dL and an elevated blood urea nitrogen (BUN) of 45 mg/dL. The electrolytes showed mild hyperkalemia, with a potassium level of 5.6 mEq/L, necessitating immediate intervention to prevent cardiac complications. A renal ultrasound confirmed mild hydronephrosis and suggested a possible obstructive component, correlating with the patient's flank pain and decreased urine output. These findings prompted a nephrology consultation to evaluate the need for potential interventions such as nephrostomy or ureteral stenting.

The team also conducted a thorough review of the patient's medication regimen, identifying rifampin as a potential contributor to the nephrotoxicity. Given this insight, the infectious disease specialist recommended substituting rifampin with a less nephrotoxic alternative, considering the drug susceptibility profile. The integration of these diagnostic results into the patient's care plan guided the adjustment of therapeutic strategies, underscoring the importance of continuous monitoring and multidisciplinary collaboration to address the challenges posed by the complex interplay of multi-drug resistant tuberculosis and secondary infections.

Section 4

Response to Interventions:

Following the adjustment in the patient's treatment regimen, the healthcare team closely monitored the response to the interventions aimed at addressing both the resistant Pseudomonas aeruginosa infection and the renal complications. The patient's antibiotic therapy was optimized based on the sensitivity results, switching to an aminoglycoside that showed efficacy against the resistant strain, while careful monitoring for ototoxicity and nephrotoxicity was initiated. Concurrently, the infectious disease specialist transitioned the patient from rifampin to levofloxacin, considering both its anti-tubercular efficacy and reduced renal impact.

In the days following these changes, the patient's clinical status revealed mixed responses. On a positive note, their respiratory symptoms showed slight improvement, with a reduction in the frequency and severity of coughing spells, and oxygen saturation levels stabilized around 92% on room air. However, the renal parameters remained a concern, as the serum creatinine level further increased to 3.1 mg/dL, indicating ongoing renal stress despite the medication adjustments. The nephrology team decided to proceed with a ureteral stenting procedure to relieve the suspected obstruction contributing to the hydronephrosis, aiming to preserve renal function.

The nursing team played a crucial role in evaluating the patient's fluid status and providing interventions to address the mild hyperkalemia, which had decreased to 5.3 mEq/L following administration of sodium polystyrene sulfonate. Continuous cardiac monitoring was maintained to promptly detect any arrhythmias. The patient's journey highlighted the need for vigilant assessment and timely adaptation of therapeutic strategies, as the complexities of multi-drug resistant infections and renal impairment posed significant challenges. As the patient continued to respond to interventions, the healthcare team remained alert for any emerging complications, ready to adjust the care plan as necessary to optimize outcomes.

Section 5

New Complications

As the patient's treatment continued, new complications emerged that required immediate attention. On the morning of the fifth day post-intervention adjustments, the nursing team observed a subtle yet worrying change in the patient's neurological status. The patient exhibited mild confusion and disorientation, struggling to recall the day and location. This prompted an urgent reassessment of potential causes, given the complex interplay of existing conditions and treatments. A non-contrast CT scan of the brain was ordered to rule out any acute intracranial events, while serum electrolyte levels were rechecked, revealing a sodium level of 129 mEq/L, indicating mild hyponatremia.

Simultaneously, the patient's renal function continued to deteriorate despite the ureteral stenting. The serum creatinine level rose further to 3.5 mg/dL, accompanied by a developing metabolic acidosis, with bicarbonate levels dropping to 18 mEq/L and a pH of 7.32 on arterial blood gas analysis. The nephrology team contemplated initiating renal replacement therapy, weighing the risks and benefits in the context of the patient's already compromised state. The infectious disease specialist also reconsidered the antibiotic regimen, brainstorming with the team to minimize nephrotoxic agents while maintaining efficacy against the resistant infections.

This turn of events necessitated a collaborative approach, with the healthcare team focusing on a comprehensive review of the patient's fluid balance, medication side effects, and potential drug interactions contributing to the current clinical picture. The primary goal was to stabilize the patient's condition, address the electrolyte imbalances, and prevent further neurological decline. As the team prepared to implement these critical adjustments, continuous monitoring and reassessment became paramount to anticipate and manage any further complications.